--Moderna RSV Shot Efficacy Lower Than Rivals', CDC Data Shows; Shares Down 9.5%-February 2024-www.financetom.com

--Moderna RSV Shot Efficacy Lower Than Rivals', CDC Data Shows; Shares Down 9.5%

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Moderna RSV Shot Efficacy Lower Than Rivals', CDC Data Shows; Shares Down 9.5%

Jun 26, 2024 12:19 PM

02:53 PM EDT, 06/26/2024 (MT Newswires) --

Price: 125.15, Change: -12.46, Percent Change: -9.05

Previous page： Accenture names Angie Park as new CFO Next page： Protagonist Therapeutics Insider Sold Shares Worth $280,000, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Accenture names Angie Park as new CFO

Jun 11, 2024

June 11 (Reuters) - Accenture ( ACN ) said on Tuesday that Angie Park, currently leading its Business and Commercial Finance division, will take on the role of the company's CFO on December 1. ...

Protagonist Therapeutics Insider Sold Shares Worth $280,000, According to a Recent SEC Filing

Jun 11, 2024

04:37 PM EDT, 06/11/2024 (MT Newswires) -- William D. Waddill, Director, on June 07, 2024, sold 8,000 shares in Protagonist Therapeutics ( PTGX ) for $280,000. Following the Form 4 filing with the SEC, Waddill has control over a total of 12,000 shares of the company, with 12,000 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1377121/000110465924070420/xslF345X03/tm2416932-2_4seq1.xml Price: 35.97, Change: +2.02, Percent Change:...

National Bank to buy Canadian Western Bank in C$5 bln deal

Jun 11, 2024

June 11 (Reuters) - National Bank of Canada ( NTIOF ) has agreed to buy Canadian Western Bank ( CWESF ) in a deal valued at C$5 billion, the companies said on Tuesday. ...

Protagonist Therapeutics Insider Sold Shares Worth $1,231,650, According to a Recent SEC Filing

Jun 11, 2024

04:37 PM EDT, 06/11/2024 (MT Newswires) -- Dinesh V Patel, Director, President and CEO, on June 07, 2024, sold 35,000 shares in Protagonist Therapeutics ( PTGX ) for $1,231,650. Following the Form 4 filing with the SEC, Patel has control over a total of 515,415 shares of the company, with 515,415 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1377121/000110465924070419/xslF345X03/tm2416932-1_4seq1.xml Price: 35.97, Change:...